• Who we are
  • CD28 targeting
  • How it works

Pipeline

Bispecific antibody programs

Bispecific antibody programs

Multispecific antibody programs

Monoclonal antibody programs

Monoclonal antibody programs

Multispecific antibody programs

Back

Press release ESMO 2025

Read more

LinkedIn